We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Urine Test Could Predict Outcome of Cartilage Transplant Surgery

By LabMedica International staff writers
Posted on 18 Sep 2025

Cartilage transplant surgery provides an alternative to artificial joint replacements by using donor tissue to restore knee function. More...

While many patients benefit, outcomes can vary, leaving uncertainty about who is most likely to succeed. Now, new research has revealed that urine samples contain protein biomarkers that may help predict surgical results, offering a noninvasive way to guide treatment decisions before performing any invasive procedures.

A team of researchers at the University of Missouri (Columbia, MO, USA) has been investigating biological markers to predict the outcomes of osteochondral allograft transplantation, a knee procedure that replaces damaged cartilage with healthy donor tissue. This approach preserves the patient’s natural joint rather than relying on artificial materials. The team analyzed protein biomarkers in urine, which fluctuate with age and other factors, making them dynamic indicators for surgical candidacy that can change over time.

The study identified nine proteins strongly associated with poor outcomes after surgery. Patients with elevated levels of these proteins were significantly less likely to experience success with the transplant. The findings, published in The Journal of Knee Surgery, demonstrate the potential for urine-based biomarker testing to guide patient selection and improve precision in orthopedic medicine.

This discovery could empower patients and clinicians to make more informed choices about the timing and type of knee surgery. Because biomarker levels are not fixed, patients who are not initially good candidates may later qualify, enabling flexible and personalized care. The research marks a shift from optimizing the surgery itself to optimizing the patient for surgery, laying the groundwork for more tailored orthopedic solutions.

“We’ve spent 15 years focused on optimizing the surgery for the patient, and now we are focusing on optimizing the patient for the surgery. These protein biomarkers give us important clues as to who can best benefit from this particular surgery,” said Jimi Cook, DVM ‘94, PhD ‘98, who led the research team. “By better understanding which protein biomarkers are linked with unsuccessful outcomes, we can determine the best data-driven treatment plan for each individual with knee pain before doing any invasive procedures.”

Related Links:
University of Missouri


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.